Menu

New Nature publication; MSKCC uses TLA to QC CRISPR-mediated genome editing

3 March 2017

On March 3rd, a new paper from the Memorial Sloan Kettering Cancer Center was published in Nature, entitled: "Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection".

 

The Targeted Locus Amplification (TLA) technology was used to sequence and map the AAV integrations.

 

 

VIEW THE PAPER

 

 

© 2012-2019 Cergentis B.V. All rights reserved.
For Research Use Only.Not for use in diagnostic procedures.
We use cookies for website analysis and marketing. By visiting and using our website you accept these cookies.
ACCEPT